{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:58:08Z","timestamp":1791849488438,"version":"4.3.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,2,23]]},"DOI":"10.7759\/cureus.13523","type":"journal-article","created":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T03:21:56Z","timestamp":1614136916000},"source":"Crossref","is-referenced-by-count":39,"title":["Diabetes Insipidus: Pathogenesis, Diagnosis, and Clinical Management"],"prefix":"10.7759","author":[{"given":"Cody M","family":"Mutter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Menze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariah","family":"Zakharia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoang","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-019-0103-2","article-title":"Diabetes insipidus","volume":"5","author":"Christ-Crain M","year":"2019","unstructured":"Christ-Crain M, Bichet DG, Fenske WK, Goldman MB, Rittig S, Verbalis JG, Verkman AS. Diabetes insipidus. Nat Rev Primers. 2019, 5:54. 10.1038\/s41572-019-0103-2","journal-title":"Nat Rev Primers"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1210\/er.2012-1044","article-title":"Nephrogenic diabetes insipidus: essential insights into the molecular background and potential therapies for treatment","volume":"34","author":"Moeller HB","year":"2013","unstructured":"Moeller HB, Rittig S, Fenton RA. Nephrogenic diabetes insipidus: essential insights into the molecular background and potential therapies for treatment. Endocrine Rev. 2013, 34:278-301. 10.1210\/er.2012-1044","journal-title":"Endocrine Rev"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8529(05)70207-3","article-title":"Antidiuretic hormone: normal and disordered function","volume":"30","author":"Robertson GL","year":"2001","unstructured":"Robertson GL. Antidiuretic hormone: normal and disordered function. Endocrinology. 2001, 30:671-694. 10.1016\/S0889-8529(05)70207-3","journal-title":"Endocrinology"},{"key":"ref4","article-title":"Fluid and metabolic disorders in neuroscience patients","author":"Hickey J","unstructured":"Hickey J. Fluid and metabolic disorders in neuroscience patients. The Clinical Practice of Neurological and Neurosurgical Nursing. 2009 (ed): Lippincott Williams & Wilkins, Philadelphia, PA; 195-205."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00234-018-2072-7","article-title":"Neuroimaging of central diabetes insipidus\u2014when, how and findings","volume":"60","author":"Adams NC","year":"2018","unstructured":"Adams NC, Farrell TP, O\u2019Shea A. Neuroimaging of central diabetes insipidus\u2014when, how and findings. Neuroradiology. 2018, 60:995-1012. 10.1007\/s00234-018-2072-7","journal-title":"Neuroradiology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2017.01.002","article-title":"Genetics of diabetes insipidus","volume":"46","author":"Schernthaner-Reiter MH","year":"2017","unstructured":"Schernthaner-Reiter MH, Stratakis CA, Luger A. Genetics of diabetes insipidus. Endocrinol Metabol Clin N Am. 2017, 46:305-334. 10.1016\/j.ecl.2017.01.002","journal-title":"Endocrinol Metabol Clin N Am"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M310331200","article-title":"Wolframin expression induces novel ion channel activity in endoplasmic reticulum membranes and increases intracellular calcium","volume":"278","author":"Osman AA","year":"2003","unstructured":"Osman AA, Saito M, Makepeace C, Permutt MA, Schlesinger P, Mueckler M. Wolframin expression induces novel ion channel activity in endoplasmic reticulum membranes and increases intracellular calcium. J Biol Chem. 2003, 278:52755-52762. 10.1074\/jbc.M310331200","journal-title":"J Biol Chem"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M507426200","article-title":"WFS1 Is a novel component of the unfolded protein response and maintains homeostasis of the endoplasmic reticulum in pancreatic \u03b2-cells","volume":"280","author":"Fonseca SG","year":"2005","unstructured":"Fonseca SG, Fukuma M, Lipson KL, Nguyen LX, Allen JR, Oka Y, Urano F. WFS1 Is a novel component of the unfolded protein response and maintains homeostasis of the endoplasmic reticulum in pancreatic \u03b2-cells. J Biol Chem. 2005, 280:39609-39615. 10.1074\/jbc.M507426200","journal-title":"J Biol Chem"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)92473-6","article-title":"Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome","volume":"346","author":"Barrett TG","year":"1995","unstructured":"Barrett TG, Bundey SE, Macleod AF. Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome. Lancet. 1995, 346:1458-1463. 10.1016\/S0140-6736(95)92473-6","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-144-3-200602070-00007","article-title":"Nephrogenic diabetes insipidus","volume":"144","author":"Sands JM","year":"2006","unstructured":"Sands JM, Bichet DG. Nephrogenic diabetes insipidus. Ann Intern Med. 2006, 144:186-194. 10.7326\/0003-4819-144-3-200602070-00007","journal-title":"Ann Intern Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1159\/000336333","article-title":"Diabetes insipidus\u2014diagnosis and management","volume":"77","author":"Iorgi ND","year":"2012","unstructured":"Iorgi ND, Napoli F, Allegri AEM, et al.. Diabetes insipidus\u2014diagnosis and management. Hormone Res Paediatrics. 2012, 77:69-84. 10.1159\/000336333","journal-title":"Hormone Res Paediatrics"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199921060-00002","article-title":"Drug-induced diabetes insipidus: incidence, prevention and management","volume":"21","author":"Bendz H","year":"1999","unstructured":"Bendz H, Aurell M. Drug-induced diabetes insipidus: incidence, prevention and management. Drug Safety. 1999, 21:449-456.  10.2165\/00002018-199921060-00002","journal-title":"Drug Safety"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-005-0397-0","article-title":"Dipsogenic diabetes insipidus: report of a novel treatment strategy and literature review","volume":"10","author":"Perkins RM","year":"2006","unstructured":"Perkins RM, Yuan CM, Welch PG. Dipsogenic diabetes insipidus: report of a novel treatment strategy and literature review. Clin Exp Nephrol. 2006, 10:63-67. 10.1007\/s10157-005-0397-0","journal-title":"Clin Exp Nephrol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4414\/smw.2017.14514","article-title":"Primary polydipsia in the medical and psychiatric patient: characteristics, complications and therapy","volume":"147","author":"Sailer CO","year":"2017","unstructured":"Sailer CO, Winzeler B, Christ-Crain M. Primary polydipsia in the medical and psychiatric patient: characteristics, complications and therapy. Swiss Medical Weekly. 2017, 147:10.4414\/smw.2017.14514","journal-title":"Swiss Medical Weekly"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2016.02.005","article-title":"Diabetes insipidus during pregnancy","volume":"30","author":"Ananthakrishnan S","year":"2016","unstructured":"Ananthakrishnan S. Diabetes insipidus during pregnancy. Best Pract Res Clin Endocrinol Metab. 2016, 30:305-315. 10.1016\/j.beem.2016.02.005","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2020.101384","article-title":"Gestational diabetes insipidus: diagnosis and management","volume":"34","author":"Ananthakrishnan S.","year":"2020","unstructured":"Ananthakrishnan S.. Gestational diabetes insipidus: diagnosis and management. Best Pract Res Clin Endocrinol Metab. 2020, 34:101384. 10.1016\/j.beem.2020.101384","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-4507","article-title":"Diagnostic accuracy of copeptin in the differential diagnosis of the polyuria-polydipsia syndrome: a prospective multicenter study","volume":"100","author":"Timper K","year":"2015","unstructured":"Timper K, Fenske W, K\u00fchn F, et al.. Diagnostic accuracy of copeptin in the differential diagnosis of the polyuria-polydipsia syndrome: a prospective multicenter study. J Clin Endocrinol Metab. 2015, 100:2268-2274. 10.1210\/jc.2014-4507","journal-title":"J Clin Endocrinol Metab"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2015.224","article-title":"Copeptin in the diagnosis of vasopressin-dependent disorders of fluid homeostasis","volume":"12","author":"Christ-Crain M","year":"2016","unstructured":"Christ-Crain M, Fenske W. Copeptin in the diagnosis of vasopressin-dependent disorders of fluid homeostasis. Nat Rev Endocrinol. 2016, 12:168-176. 10.1038\/nrendo.2015.224","journal-title":"Nat Rev Endocrinol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-4507","article-title":"Copeptin in the differential diagnosis of the polydipsia-polyuria syndrome\u2014revisiting the direct and indirect water deprivation tests","volume":"96","author":"Fenske W","year":"2011","unstructured":"Fenske W, Quinkler M, Lorenz D, et al.. Copeptin in the differential diagnosis of the polydipsia-polyuria syndrome\u2014revisiting the direct and indirect water deprivation tests.  J Clin Endocrinol Metab. 2011, 96:1506-1515. 10.1210\/jc.2014-4507","journal-title":"J Clin Endocrinol Metab"},{"key":"ref20","article-title":"Urinalysis: a comprehensive review","volume":"71","author":"Simerville JA","year":"2005","unstructured":"Simerville JA, Maxted WC, Pahira JJ. Urinalysis: a comprehensive review. Am Fam Physician. 2005, 71:1153-1162.","journal-title":"Am Fam Physician"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.4037\/ccn2012904","article-title":"Central neurogenic diabetes insipidus, syndrome of inappropriate secretion of antidiuretic hormone, and cerebral salt-wasting syndrome in traumatic brain injury","volume":"32","author":"John CA.","year":"2012","unstructured":"John CA., Day MW. Central neurogenic diabetes insipidus, syndrome of inappropriate secretion of antidiuretic hormone, and cerebral salt-wasting syndrome in traumatic brain injury. Critical Care Nurse. 2012, 32:e1-e7. 10.4037\/ccn2012904","journal-title":"Critical Care Nurse"},{"key":"ref22","article-title":"Diabetes insipidus","author":"Hui C","year":"2020","unstructured":"Hui C, Radbel JM. Diabetes insipidus. StatPearls, Treasure Island, FL; 2020."},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2020.05.012","article-title":"Diabetes insipidus","volume":"49","author":"Refardt J","year":"2020","unstructured":"Refardt J, Winzeler B, Christ-Crain M. Diabetes insipidus. Endocrinol Metab Clin N Am. 2020, 49:517-531. 10.1016\/j.ecl.2020.05.012","journal-title":"Endocrinol Metab Clin N Am"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13991","article-title":"Copeptin and its role in the diagnosis of diabetes insipidus and the syndrome of inappropriate antidiuresis","volume":"91","author":"Refardt J","year":"2019","unstructured":"Refardt J, Winzeler B, Christ\u2010Crain M. Copeptin and its role in the diagnosis of diabetes insipidus and the syndrome of inappropriate antidiuresis. Clin Endocrinol. 2019, 91:22-32. 10.1111\/cen.13991","journal-title":"Clin Endocrinol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2020.101398","article-title":"Diagnosis and differential diagnosis of diabetes insipidus: update","volume":"34","author":"Refardt J","year":"2020","unstructured":"Refardt J. Diagnosis and differential diagnosis of diabetes insipidus: update. Best Pract Res Clin Endocrinol Metab. 2020, 34:101398. 10.1016\/j.beem.2020.101398","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198112243052601","article-title":"A comparison of plasma vasopressin measurements with a standard indirect test in the differential diagnosis of polyuria","volume":"305","author":"Zerbe RL","year":"1981","unstructured":"Zerbe RL, Robertson GL. A comparison of plasma vasopressin measurements with a standard indirect test in the differential diagnosis of polyuria. N Engl J Med. 1981, 305:1539-1546. 10.1056\/NEJM198112243052601","journal-title":"N Engl J Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1159\/000505548","article-title":"Diabetes insipidus: new concepts for diagnosis","volume":"110","author":"Christ-Crain M","year":"2020","unstructured":"Christ-Crain M. Diabetes insipidus: new concepts for diagnosis. Neuroendocrinology. 2020, 110:859-867. 10.1159\/000505548","journal-title":"Neuroendocrinology"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1803760","article-title":"A copeptin-based approach in the diagnosis of diabetes insipidus","volume":"379","author":"Fenske W","year":"2018","unstructured":"Fenske W, Refardt J, Chifu I, et al.. A copeptin-based approach in the diagnosis of diabetes insipidus. N Engl J Med. 2018, 379:428-439. 10.1056\/NEJMoa1803760","journal-title":"N Engl J Med"},{"key":"ref29","article-title":"Treatment of Central Diabetes Insipidus","author":"Bichet D","year":"2019","unstructured":"Bichet D, Sterns RH, Emmett M, Wolfsdorf JI. Treatment of Central Diabetes Insipidus. Forman JP, Hoppin A (ed): UpToDate, Waltham, MA; 2019."},{"key":"ref30","article-title":"Treatment of Nephrogenic Diabetes Insipidus","author":"Bichet D.","year":"2019","unstructured":"Bichet D., Sterns R. H., Mattoo T. K.. Treatment of Nephrogenic Diabetes Insipidus. UpToDate, Forman, J. P.. 2019,","journal-title":"UpToDate, Forman, J. P."},{"key":"ref31","unstructured":"Diabetes Insipidus | NIDDK. (n.d.). Accessed. September 7, 2020: https:\/\/www.niddk.nih.gov\/health-information\/kidney-disease\/diabetes-insipidus."},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000143476.93376.04","article-title":"Antidiuretic effect of hydrochlorothiazide in lithium-induced nephrogenic diabetes insipidus is associated with upregulation of aquaporin-2, Na-Cl Co-transporter, and epithelial sodium channel","volume":"15","author":"Kim GH","year":"2004","unstructured":"Kim GH. Antidiuretic effect of hydrochlorothiazide in lithium-induced nephrogenic diabetes insipidus is associated with upregulation of aquaporin-2, Na-Cl Co-transporter, and epithelial sodium channel. J Am Soc Nephrol. 2004, 15:2836-2843. 10.1097\/01.ASN.0000143476.93376.04","journal-title":"J Am Soc Nephrol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2014.10","article-title":"Combination of secretin and fluvastatin ameliorates the polyuria associated with X-linked nephrogenic diabetes insipidus in mice","volume":"86","author":"Procino G","year":"2014","unstructured":"Procino G, Milano S, Carmosino M, et al.. Combination of secretin and fluvastatin ameliorates the polyuria associated with X-linked nephrogenic diabetes insipidus in mice. Kidney Int. 2014, 86:127-138. 10.1038\/ki.2014.10","journal-title":"Kidney Int"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12973","article-title":"A double-blind, randomized, placebo-controlled pilot trial of atorvastatin for nephrogenic diabetes insipidus in lithium users","volume":"23","author":"Fotso Soh J","year":"2020","unstructured":"Fotso Soh J, Beaulieu S, Trepiccione F, et al.. A double-blind, randomized, placebo-controlled pilot trial of atorvastatin for nephrogenic diabetes insipidus in lithium users. Bipolar Disorders. 2020, 23:66-75. 10.1111\/bdi.12973","journal-title":"Bipolar Disorders"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1097\/00006254-199807000-00025","article-title":"DDAVP use during pregnancy: an analysis of its safety for mother and child","volume":"53","author":"Ray JG","year":"1998","unstructured":"Ray JG. DDAVP use during pregnancy: an analysis of its safety for mother and child. Obstet Gynecol Surv. 1998, 53:450-455. 10.1097\/00006254-199807000-00025","journal-title":"Obstet Gynecol Surv"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/s0029-7844(97)00029-x","article-title":"Diabetes insipidus in pregnancy: a treatable cause of oligohydramnios","volume":"89","author":"Hanson RS","year":"1997","unstructured":"Hanson RS, Powrie RO, Larson L. Diabetes insipidus in pregnancy: a treatable cause of oligohydramnios. Obstet Gynecol. 1997, 89:816-817. 10.1016\/s0029-7844(97)00029-x","journal-title":"Obstet Gynecol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1272\/jnms.JNMS.2018_85-29","article-title":"Diabetes insipidus presenting with oligohydramnios and polyuria during pregnancy","volume":"85","author":"Choi HS","year":"2018","unstructured":"Choi HS, Kim YH, Kim CS, Ma SK, Kim SW, & Bae EH. Diabetes insipidus presenting with oligohydramnios and polyuria during pregnancy. J Nippon Med School. 2018, 85:191-193. 10.1272\/jnms.JNMS.2018_85-29","journal-title":"J Nippon Med School"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v6.i2.234","article-title":"Type 2 diabetes after gestational diabetes: the influence of changing diagnostic criteria","volume":"6","author":"Noctor E","year":"2015","unstructured":"Noctor E. Type 2 diabetes after gestational diabetes: the influence of changing diagnostic criteria. World J Diab. 2015, 6:234-244. 10.4239\/wjd.v6.i2.234","journal-title":"World J Diab"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1111\/tog.12450","article-title":"Diabetes insipidus in pregnancy","volume":"20","author":"Quigley J","year":"2018","unstructured":"Quigley J, Shelton C, Issa B, Sripada S. Diabetes insipidus in pregnancy. Obstet Gynaecol. 2018, 20:41-48. 10.1111\/tog.12450","journal-title":"Obstet Gynaecol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/45123-diabetes-insipidus-pathogenesis-diagnosis-and-clinical-management","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:24:53Z","timestamp":1707506693000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/45123-diabetes-insipidus-pathogenesis-diagnosis-and-clinical-management"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,23]]},"references-count":39,"URL":"https:\/\/doi.org\/10.7759\/cureus.13523","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2,23]]}}}